AstraZeneca PLCAZN announced positive results from a safety study on Symbicort inhaler in patients suffering from asthma compared to budesonide alone. Symbicort is presently marketed for the treatment ...
Symbicort and Advair are similar brand-name prescription medications that treat asthma and COPD. They contain slightly different active ingredients. Symbicort and Advair are two drugs that treat ...
AstraZenecaAZN announced that the FDA has granted six months of pediatric exclusivity to its Symbicort inhalation aerosol. Symbicort is a combination formulation containing budesonide, an inhaled ...
LargePharma_SymbicortAstraZeneca’s Symbicort, the second-to-market ICS/LABA combo behind GlaxoSmithKline’s Advair, faced an uphill battle on its launch in June 2007, squaring off against a firmly ...
AstraZeneca’s aging respiratory giant Symbicort won a coveted pediatric exclusivity nod from the FDA on Wednesday, giving the brand a longer life—and potentially hundreds of millions in additional ...
MISSISSAUGA, ON, Sept. 30, 2019 /CNW/ - AstraZeneca Canada announced today that Health Canada has approved the expanded use of Symbicort ® Turbuhaler ® (budesonide ...
PITTSBURGH, Nov. 10, 2022 /PRNewswire/ -- Viatris Inc. (NASDAQ: VTRS), a global healthcare company, today announced that it and Kindeva Drug Delivery L.P. have won a significant court decision in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback